Literature DB >> 11285196

Dietary energy restriction inhibits ERK but not JNK or p38 activity in the epidermis of SENCAR mice.

Y Liu1, E Duysen, A L Yaktine, A Au, W Wang, D F Birt.   

Abstract

Ongoing studies in our laboratory have demonstrated that dietary energy restriction (DER) inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced AP-1 transcription factor binding to DNA in the epidermis of SENCAR mice. To dissect the specific signal transduction pathways through which DER inhibits the AP-1:DNA binding, we analyzed the activities of three major MAP kinases that lead to the induction of AP-1. The changes in ERK1 and ERK2 protein expression and phosphorylation were further characterized by western blot analysis. Female SENCAR mice were pre-fed ad libitum (AL) or 40% DER diet for 8-10 weeks. The kinase activities in mouse epidermis were determined by immune complex kinase assays at 0.5, 1, 4, or 6 h following treatment with 3.2 nmol TPA to the shaved dorsal backs. ERK activity at 1 h post-TPA treatment was nearly 5-fold (P< 0.005) above basal levels in AL mice while the increase was abolished in DER mice. The TPA-induced ERK activity in AL mice was accompanied by increased phosphorylation of ERK1 and ERK2 (P< 0.05), which was abrogated in DER mice. In addition, DER mice exhibited reduced expression of total ERK1 and ERK2 and higher proportions of ERK1 and ERK2 phosphorylation in comparison with AL mice (P<0.05). JNK activity was decreased at 1 and 6 h but increased at 4 h (P<0.05) post-TPA treatment. TPA did not change p38 kinase activity at the time points tested. Neither JNK nor p38 activity was altered by DER. Taken together, our results indicated for the first time that DER blocked the TPA stimulation of ERK activity and suggested that the inhibition of TPA-induced AP-1 activity by DER is likely through inhibition of ERK but not JNK or p38 kinase pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11285196     DOI: 10.1093/carcin/22.4.607

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Effect of ultraviolet B radiation on activator protein 1 constituent proteins and modulation by dietary energy restriction in SKH-1 mouse skin.

Authors:  Brian D Hopper; Joseph Przybyszewski; Haw-Wen Chen; Kimberly D P Hammer; Diane F Birt
Journal:  Mol Carcinog       Date:  2009-09       Impact factor: 4.784

2.  Shikonin reduces oedema induced by phorbol ester by interfering with IkappaBalpha degradation thus inhibiting translocation of NF-kappaB to the nucleus.

Authors:  I Andújar; M C Recio; T Bacelli; R M Giner; J L Ríos
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

3.  Energy balance modulates mouse skin tumor promotion through altered IGF-1R and EGFR crosstalk.

Authors:  Tricia Moore; Linda Beltran; Steve Carbajal; Stephen D Hursting; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2012-08-15

Review 4.  The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive.

Authors:  Arindam Dhar; Mathew R Young; Nancy H Colburn
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

5.  Fibroblast growth factor receptor is a mechanistic link between visceral adiposity and cancer.

Authors:  D Chakraborty; V Benham; B Bullard; T Kearney; H C Hsia; D Gibbon; E Y Demireva; S Y Lunt; J J Bernard
Journal:  Oncogene       Date:  2017-08-07       Impact factor: 9.867

Review 6.  Ras signaling in aging and metabolic regulation.

Authors:  Cathy Slack
Journal:  Nutr Healthy Aging       Date:  2017-12-07

7.  Engineered Resistant-Starch (ERS) Diet Shapes Colon Microbiota Profile in Parallel with the Retardation of Tumor Growth in In Vitro and In Vivo Pancreatic Cancer Models.

Authors:  Concetta Panebianco; Kaarel Adamberg; Signe Adamberg; Chiara Saracino; Madis Jaagura; Kaia Kolk; Anna Grazia Di Chio; Paolo Graziano; Raivo Vilu; Valerio Pazienza
Journal:  Nutrients       Date:  2017-03-27       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.